Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Virgin Wines UK (VINO) by Steve Moore in ShareProphets
- Hold SEGRO (SGRO) by Jefferies
- Avoid Pennant International Group (PEN) by Steve Moore in ShareProphets
- Buy CMC Markets (CMCX) by Paul Summers in The Motley Fool
- Buy AstraZeneca (AZN) by LBBW
- Watch Empresaria Group (EMR) by Steve Moore in ShareProphets
- Buy Centamin (DI) (CEY) by Nigel Somerville in ShareProphets
- Neutral Ryanair Holdings (CDI) (0RYA) by UBS
- Buy Relx plc (REL) by UBS
- Sell Unilever (ULVR) by UBS
- Hold AstraZeneca (AZN) by DZ Bank
- Buy British American Tobacco (BATS) by Deutsche Bank
- Hold Hammerson (HMSO) by Deutsche Bank
- Buy Computacenter (CCC) by Jefferies
- Buy Man Group (EMG) by Goldman Sachs
- Sell Deliveroo Class (ROO) by Redburn
- Buy Unilever (ULVR) by Deutsche Bank
- Buy 3i Group (III) by Lauren Almeida in The Times - Tempus
- Overweight BT Group (BT.A) by Barclays
- Overweight IG Group Holdings (IGG) by Barclays
Sareum Holdings (SAR) Share Price
Health Care Sector
NOTE: This is based on 3 open tips for Sareum Holdings (SAR)
| Latest Bid : 31.00p | Latest Ask : 33.00p |
| High Today : 33.00p | Low Today : 31.11p |
| This Years High : 105.50p | This Years Low : 10.25p |
| Volume : 142,580 | MKT Cap : £33.92M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Sareum Holdings (SAR) Overview
Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.Sareum Holdings (SAR) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Peel Hunt | Premium Only | 2023-06-06 14:15:00 06/06/2023 | -77.14% |
| Long Term Buy | Royston Wild | Premium Only | 2021-08-22 07:55:00 22/08/2021 | -91.69% |
| Sell | Gary Newman | Premium Only | 2016-03-14 08:56:04 14/03/2016 | -15.25% |
Sareum Holdings (SAR) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 31.00p | Latest Ask : 33.00p |
| High Today : 33.00p | Low Today : 31.11p |
| This Years High : 105.50p | This Years Low : 10.25p |
| Volume : 142,580 | MKT Cap : £33.92M |
Sareum Holdings Overview
Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Sareum Holdings Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Peel Hunt | Premium Only | 2023-06-06 14:15:00 06/06/2023 | -77.14% |
| Long Term Buy | Royston Wild | Premium Only | 2021-08-22 07:55:00 22/08/2021 | -91.69% |
| Sell | Gary Newman | Premium Only | 2016-03-14 08:56:04 14/03/2016 | -15.25% |